pharmaceutical investing Verona Pharma plc Operational Update and Financial Results for the First Quarter Ended March 31, 2018
medical device investing AIT Therapeutics Receives Patent Allowance for Delivery of Inhaled Nitric Oxide at Concentrations of at Least 160ppm for Treatment of Bronchiolitis in Infants
pharmaceutical investing Verona Pharma Reports Positive Top-Line Data from Phase 2b Clinical Trial of RPL554
Denison Announces Closing of Transaction with Skyharbour and Formation of Four Prospective Exploration Joint Ventures Proximal to Wheeler River
Skyharbour Closes Major Strategic Transaction with Denison Mines to Form Four New Joint Ventures at Russell Lake with Combined Project Consideration up to $61.5 Million
